Your browser doesn't support javascript.
loading
Cardiovascular Disease in Primary Sjögren's Syndrome.
Berardicurti, Onorina; Ruscitti, Piero; Cipriani, Paola; Ciccia, Francesco; Liakouli, Vasiliki; Guggino, Giuliana; Carubbi, Francesco; Di Benedetto, Paola; Triolo, Giovanni; Giacomelli, Roberto.
Afiliación
  • Berardicurti O; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Ruscitti P; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Cipriani P; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Ciccia F; Division of Rheumatology, University of Palermo, Palermo, Italy.
  • Liakouli V; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Guggino G; Division of Rheumatology, University of Palermo, Palermo, Italy.
  • Carubbi F; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Di Benedetto P; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
  • Triolo G; Division of Rheumatology, University of Palermo, Palermo, Italy.
  • Giacomelli R; Division of Rheumatology, University of L`Aquila, L`Aquila, Italy.
Rev Recent Clin Trials ; 13(3): 164-169, 2018.
Article en En | MEDLINE | ID: mdl-29542415
ABSTRACT

BACKGROUND:

A close relationship between rheumatic diseases and cardiovascular disease (CVD) has been reported, accounting for the higher mortality and morbidity observed in these patients. In the last years, it has been clearly reported that patients affected by primary Sjögren's syndrome (pSS) experienced an increased risk of CVD.

OBJECTIVE:

This review aimed at investigating CVD, traditional cardiovascular (CV) risk factors and possible targeted therapeutic strategies in pSS patients.

METHOD:

Available literature concerning CV risk factors in pSS patients has been selected and discussed.

CONCLUSION:

Disease-related characteristics and traditional CV risk factors contribute to observed atherosclerotic damage in pSS patients. The pro-inflammatory mediators together with hypertension and type 2 diabetes, which are more prevalent in pSS patients, determine the increased CV burden. Future studies are needed to fully elucidate the role of possible targeted therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome de Sjögren Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Rev Recent Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome de Sjögren Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Rev Recent Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Italia
...